Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Total Valuation
Harrow Health has a market cap or net worth of $884.85M. The enterprise value is $1.38B.
Market Cap$884.85M
Enterprise Value$1.38B
Share Statistics
Harrow Health has 36,685,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,685,170
Owned by Insiders26.74%
Owned by Institutions0.08%
Financial Efficiency
Harrow Health’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 2.94%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)2.94%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee522.55B
Profits Per Employee-45.76B
Employee Count382
Asset Turnover0.51
Inventory Turnover4.60
Valuation Ratios
The current PE Ratio of Harrow Health is -68.42. Harrow Health’s PEG ratio is 1.97.
PE Ratio-68.42
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF-19.65
Price to Operating Cash Flow-53.87
PEG Ratio1.97
Income Statement
In the last 12 months, Harrow Health had revenue of 10.00T> and earned -17.48M in profits. Earnings per share was -0.49.
Revenue10.00T>
Gross Profit10.00T>
Operating Income8.82T
Pretax Income-17.32T
Net Income-17.48M
EBITDA8.82T
Earnings Per Share (EPS)-0.49
Cash Flow
In the last 12 months, operating cash flow was -22.20M and capital expenditures -38.60M, giving a free cash flow of -60.80M billion.
Operating Cash Flow-22.20M
Free Cash Flow-60.80M
Free Cash Flow per Share-1.66
Dividends & Yields
Harrow Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.61
52-Week Price Change110.34%
50-Day Moving Average24.97
200-Day Moving Average35.48
Relative Strength Index (RSI)48.31
Average Volume (3m)499.09K
Important Dates
Harrow Health upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
Harrow Health as a current ratio of 2.08, with Debt / Equity ratio of 330.21%
Current Ratio2.08
Quick Ratio1.96
Debt to Market Cap0.18
Net Debt to EBITDA<0.01
Interest Coverage Ratio387.17K
Taxes
In the past 12 months, Harrow Health has paid -161.00B in taxes.
Income Tax-161.00B
Effective Tax Rate<0.01
Enterprise Valuation
Harrow Health EV to EBITDA ratio is <0.01, with an EV/FCF ratio of -22.63.
EV to Sales<0.01
EV to EBITDA<0.01
EV to Free Cash Flow-22.63
EV to Operating Cash Flow-62.05
Balance Sheet
Harrow Health has $47.25M in cash and marketable securities with ― in debt, giving a net cash position of $181.58M billion.
Cash & Marketable Securities$47.25M
Total Debt―
Net Cash$181.58M
Net Cash Per Share$4.95
Tangible Book Value Per Share$1.94M
Margins
Gross margin is 75.33%, with operating margin of 4.42%, and net profit margin of >-0.01%.
Gross Margin75.33%
Operating Margin4.42%
Pretax Margin-8.68%
Net Profit Margin>-0.01%
EBITDA Margin4.42%
EBIT Margin<0.01%
Analyst Forecast
The average price target for Harrow Health is $59.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$59.00
Price Target Upside141.80% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast53.32%
EPS Growth Forecast33.82%